Literature DB >> 29183157

Severe Hypoglycemia in Adults With Type 1 Diabetes After Switching to Insulin Degludec.

Halis Kaan Akturk1,2, Viral N Shah1,2.   

Abstract

Entities:  

Keywords:  hypoglycemia; insulin degludec; noncompliance; seizure; type 1 diabetes

Mesh：

Substances：

Year:  2017        PMID： 29183157      PMCID： PMC6154225          DOI： 10.1177/1932296817742922

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  4 in total

1.  Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.

Authors:  Simon Heller; John Buse; Miles Fisher; Satish Garg; Michel Marre; Ludwig Merker; Eric Renard; David Russell-Jones; Areti Philotheou; Ann Marie Ocampo Francisco; Huiling Pei; Bruce Bode
Journal:  Lancet       Date:  2012-04-21       Impact factor: 79.321

2.  Timing of Meal Insulin and Its Relation to Adherence to Therapy in Type 1 Diabetes.

Authors:  Karishma A Datye; Claire T Boyle; Jill Simmons; Daniel J Moore; Sarah S Jaser; Nicole Sheanon; Julie M Kittelsrud; Stephanie E Woerner; Kellee M Miller
Journal:  J Diabetes Sci Technol       Date:  2017-09-12

3.  Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.

Authors:  Chantal Mathieu; Priscilla Hollander; Bresta Miranda-Palma; John Cooper; Edward Franek; David Russell-Jones; Jens Larsen; Søren Can Tamer; Stephen C Bain
Journal:  J Clin Endocrinol Metab       Date:  2013-02-07       Impact factor: 5.958

4.  Insulin degludec once-daily in type 2 diabetes: simple or step-wise titration (BEGIN: once simple use).

Authors:  Athena Philis-Tsimikas; Meryl Brod; Marcus Niemeyer; Ann Marie Ocampo Francisco; Jeffrey Rothman
Journal:  Adv Ther       Date:  2013-06-29       Impact factor: 3.845
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.